A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : SGLT-2 / sodium glucose cotransporter 2 inhibitors

[Related PubMed/MEDLINE]
Total Number of Papers: 10
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   SGLT-2  (>> Co-occurring Abbreviation)
Long Form:   sodium glucose cotransporter 2 inhibitors
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
1  2022 Effects of novel glucose-lowering drugs on the lipid parameters: A systematic review and meta-analysis. ---
2  2021 Canagliflozin, an SGLT-2 inhibitor, ameliorates acetic acid-induced colitis in rats through targeting glucose metabolism and inhibiting NOX2. AA, CANA
3  2021 Diabetic kidney disease: update on clinical management and non-glycaemic effects of newer medications for type 2 diabetes. DPP-4, GLP-RAs
4  2021 EMPEROR reduced - empagliflozin in patients with heart failure and reduced ejection fraction. CI, T2DM
5  2020 Evaluation of cardiovascular and renal outcomes with ertugliflozin: what is the VERdict from the VERTIS-CV trial? ASCVD, CVOTs
6  2018 A review of cardiovascular outcome trials in type 2 diabetes. CVOTs, EMA, FDA
7  2018 Metabolic Control in Type 1 Diabetes: Is Adjunctive Therapy the Way Forward? GLP-1
8  2018 Pharmacoeconomic evaluation of sodium-glucose transporter-2 (SGLT2) inhibitors for the treatment of type 2 diabetes. SGLT2
9  2017 Elements for Success in Managing Type 2 Diabetes With SGLT-2 Inhibitors: Individualizing Treatment With SGLT-2 Inhibitor Therapy in Type 2 Diabetes Mellitus. T2DM
10  2017 Systematic review of metformin monotherapy and dual therapy with sodium glucose co-transporter 2 inhibitor (SGLT-2) in treatment of type 2 diabetes mellitus. PICO, SGLT2, T2DM